Cargando…
Impact of vitamin AD(3)E treatment before application of controlled intra-vaginal drug releaser on clinical and hematologic findings, ovarian hormones, and calving rates in she-camels (Camelus dromedarius)
BACKGROUND: The scope of using controlled intra-vaginal drug releasers (CIDR) in the camel industry was small relative to that of cow, sheep, and goat. AIM: The purpose of this study was to determine the effects of intramuscular injection of AD(3)E (25 ml/400 kg) as a premedication protocol before C...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of Veterinary Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805759/ https://www.ncbi.nlm.nih.gov/pubmed/36650875 http://dx.doi.org/10.5455/OVJ.2022.v12.i6.24 |
_version_ | 1784862399763841024 |
---|---|
author | Mohamed, Ragab H. Khalphallah, Arafat Ali, Fatma Abdel-lah, Ebtsam S. Abdulkarim, Abdulrahman Elmeligy, Enas |
author_facet | Mohamed, Ragab H. Khalphallah, Arafat Ali, Fatma Abdel-lah, Ebtsam S. Abdulkarim, Abdulrahman Elmeligy, Enas |
author_sort | Mohamed, Ragab H. |
collection | PubMed |
description | BACKGROUND: The scope of using controlled intra-vaginal drug releasers (CIDR) in the camel industry was small relative to that of cow, sheep, and goat. AIM: The purpose of this study was to determine the effects of intramuscular injection of AD(3)E (25 ml/400 kg) as a premedication protocol before CIDR treatment on ovarian hormones profile and calving rate in dromedary she-camels (Camelus dromedarius) through measuring concentrations of progesterone (P4) and estradiol (E2) before, during, and after CIDR use. METHODS: The study was conducted on she-camels (C. dromedarius) (n = 24) aged between 6 and 14 years. The animals were assigned into two equal groups: CIDR treated group (CIDR(gr)) and AD(3)E plus CIDR treated group (CIDR(+)(gr)). RESULTS: Except for hemoglobin, the clinical and hematological findings showed no remarkable change either within each independent group or between CIDR(gr) and CIDR(+)(gr). Serum P4 and E2 concentrations differed significantly between the first 7 days (during CIDR use) and days from 9 to 15 (after CIDR use) in dromedary camels. Serum concentrations of P4 and E2 showed significant elevation at CIDR(+)(gr) at day 0 compared with CIDR(gr). This significant increase in serum of P4 and E2 at CIDR(+)(gr) compared to those of CIDR(gr) was also observed either during CIDR use (days 3, 5, and 7) or after CIDR use (days 9, 11, 13, and 15). During CIDR use, serum concentrations of P4 were negatively correlated with those of E2 either in CIDR(gr) or CIDR(+)(gr), however, they were positively correlated after CIDR removal either in CIDR(gr)or CIDR(+)(gr). Regarding the calving rate, it was highest in CIDR(+)(gr) whereas CIDR(gr) showed the lowest one. CONCLUSION: It was concluded that the AD(3)E pretreatment protocol of she-camels before insertion of CIDR could be used successfully during the breeding season to improve fertility in she-camels whereas the serum ovarian hormones profile and calving rates were clearly changed due to pretreatment of she-camels with AD(3)E before CIDR insertion. |
format | Online Article Text |
id | pubmed-9805759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Faculty of Veterinary Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-98057592023-01-16 Impact of vitamin AD(3)E treatment before application of controlled intra-vaginal drug releaser on clinical and hematologic findings, ovarian hormones, and calving rates in she-camels (Camelus dromedarius) Mohamed, Ragab H. Khalphallah, Arafat Ali, Fatma Abdel-lah, Ebtsam S. Abdulkarim, Abdulrahman Elmeligy, Enas Open Vet J Original Research BACKGROUND: The scope of using controlled intra-vaginal drug releasers (CIDR) in the camel industry was small relative to that of cow, sheep, and goat. AIM: The purpose of this study was to determine the effects of intramuscular injection of AD(3)E (25 ml/400 kg) as a premedication protocol before CIDR treatment on ovarian hormones profile and calving rate in dromedary she-camels (Camelus dromedarius) through measuring concentrations of progesterone (P4) and estradiol (E2) before, during, and after CIDR use. METHODS: The study was conducted on she-camels (C. dromedarius) (n = 24) aged between 6 and 14 years. The animals were assigned into two equal groups: CIDR treated group (CIDR(gr)) and AD(3)E plus CIDR treated group (CIDR(+)(gr)). RESULTS: Except for hemoglobin, the clinical and hematological findings showed no remarkable change either within each independent group or between CIDR(gr) and CIDR(+)(gr). Serum P4 and E2 concentrations differed significantly between the first 7 days (during CIDR use) and days from 9 to 15 (after CIDR use) in dromedary camels. Serum concentrations of P4 and E2 showed significant elevation at CIDR(+)(gr) at day 0 compared with CIDR(gr). This significant increase in serum of P4 and E2 at CIDR(+)(gr) compared to those of CIDR(gr) was also observed either during CIDR use (days 3, 5, and 7) or after CIDR use (days 9, 11, 13, and 15). During CIDR use, serum concentrations of P4 were negatively correlated with those of E2 either in CIDR(gr) or CIDR(+)(gr), however, they were positively correlated after CIDR removal either in CIDR(gr)or CIDR(+)(gr). Regarding the calving rate, it was highest in CIDR(+)(gr) whereas CIDR(gr) showed the lowest one. CONCLUSION: It was concluded that the AD(3)E pretreatment protocol of she-camels before insertion of CIDR could be used successfully during the breeding season to improve fertility in she-camels whereas the serum ovarian hormones profile and calving rates were clearly changed due to pretreatment of she-camels with AD(3)E before CIDR insertion. Faculty of Veterinary Medicine 2022 2022-12-12 /pmc/articles/PMC9805759/ /pubmed/36650875 http://dx.doi.org/10.5455/OVJ.2022.v12.i6.24 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Mohamed, Ragab H. Khalphallah, Arafat Ali, Fatma Abdel-lah, Ebtsam S. Abdulkarim, Abdulrahman Elmeligy, Enas Impact of vitamin AD(3)E treatment before application of controlled intra-vaginal drug releaser on clinical and hematologic findings, ovarian hormones, and calving rates in she-camels (Camelus dromedarius) |
title | Impact of vitamin AD(3)E treatment before application of controlled intra-vaginal drug releaser on clinical and hematologic findings, ovarian hormones, and calving rates in she-camels (Camelus dromedarius) |
title_full | Impact of vitamin AD(3)E treatment before application of controlled intra-vaginal drug releaser on clinical and hematologic findings, ovarian hormones, and calving rates in she-camels (Camelus dromedarius) |
title_fullStr | Impact of vitamin AD(3)E treatment before application of controlled intra-vaginal drug releaser on clinical and hematologic findings, ovarian hormones, and calving rates in she-camels (Camelus dromedarius) |
title_full_unstemmed | Impact of vitamin AD(3)E treatment before application of controlled intra-vaginal drug releaser on clinical and hematologic findings, ovarian hormones, and calving rates in she-camels (Camelus dromedarius) |
title_short | Impact of vitamin AD(3)E treatment before application of controlled intra-vaginal drug releaser on clinical and hematologic findings, ovarian hormones, and calving rates in she-camels (Camelus dromedarius) |
title_sort | impact of vitamin ad(3)e treatment before application of controlled intra-vaginal drug releaser on clinical and hematologic findings, ovarian hormones, and calving rates in she-camels (camelus dromedarius) |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805759/ https://www.ncbi.nlm.nih.gov/pubmed/36650875 http://dx.doi.org/10.5455/OVJ.2022.v12.i6.24 |
work_keys_str_mv | AT mohamedragabh impactofvitaminad3etreatmentbeforeapplicationofcontrolledintravaginaldrugreleaseronclinicalandhematologicfindingsovarianhormonesandcalvingratesinshecamelscamelusdromedarius AT khalphallaharafat impactofvitaminad3etreatmentbeforeapplicationofcontrolledintravaginaldrugreleaseronclinicalandhematologicfindingsovarianhormonesandcalvingratesinshecamelscamelusdromedarius AT alifatma impactofvitaminad3etreatmentbeforeapplicationofcontrolledintravaginaldrugreleaseronclinicalandhematologicfindingsovarianhormonesandcalvingratesinshecamelscamelusdromedarius AT abdellahebtsams impactofvitaminad3etreatmentbeforeapplicationofcontrolledintravaginaldrugreleaseronclinicalandhematologicfindingsovarianhormonesandcalvingratesinshecamelscamelusdromedarius AT abdulkarimabdulrahman impactofvitaminad3etreatmentbeforeapplicationofcontrolledintravaginaldrugreleaseronclinicalandhematologicfindingsovarianhormonesandcalvingratesinshecamelscamelusdromedarius AT elmeligyenas impactofvitaminad3etreatmentbeforeapplicationofcontrolledintravaginaldrugreleaseronclinicalandhematologicfindingsovarianhormonesandcalvingratesinshecamelscamelusdromedarius |